Priority Date: 25.10.13 (US 201361895472P)

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

  • Application ID: EP18177131
  • Status: Request for examination was made

Attorney

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Mathys & Squire LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 229 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 25.10.2013 - Priority Date (US 201361895472P)
  • 31.10.2018 - Publication A1 (EP3395814)